Suzanne Filippi

Suzanne Filippi


Email suzanne.filippi@​

Phone + 1 617 702 7797

Fax +1 617 371 1037

Practice groupCorporate

Suzanne Filippi deploys her extensive in-house and private practice experience to help clients in the life sciences and technology industries excel. Drawing on the firm's global industry prowess and her deep commitment to the "Patient First" mission of the biotech industry, she partners with clients to achieve their strategic objectives and bring vital medicines to the patients whose lives depend on them.

Suzanne has a reputation for providing creative, sophisticated, and practical advice to companies facing critical transitions – evolving from clinical to commercial stage company, going public, the onset of a hyper-growth stage, or resolving financial or regulatory challenges. Her experience includes spearheading legal teams advising on M&A, corporate governance, securities and SEC reporting, debt and equity financing, tax, and finance matters.

In her life sciences practice, Suzanne has led in-house legal teams on global clinical trials and business development transactions focused on strategic alliances and IP asset acquisitions, collaborating closely across functions. She has also advised on a variety of agreements, IP asset valuation models, portfolio strategy and patent prosecution, and options to acquire licenses.

Before joining Hogan Lovells, Suzanne held VP, Corporate Counsel Consultant roles at clinical and commercial stage biopharmaceutical companies in Cambridge – Sage Therapeutics and Aegerion Pharmaceuticals. She also served as the Senior Securities and M&A Counsel at TripAdvisor, where she spearheaded the company's US$9 billion spin-off and IPO, playing a key role in shaping its best-in-class public company infrastructure.

Suzanne's legal career began in the M&A practice at another preeminent international firm in New York, and the Business Law group of a prominent international law firm in Boston, where she represented leading companies in the life sciences, technology, and consumer goods sectors in a wide range of transactional and securities matters.

Education and admissions


J.D., Harvard Law School, 2002

B.A., Rutgers University, 1999

Representative experience

Represented Alere Inc. (f.k.a. Inverness Medical Innovations, Inc.) on its US$1.68bn hostile tender offer and acquisition of Biosite, Inc., a leader in the medical diagnostic testing industry.*

Represented Avant Immunotherapeutics, Inc. on its US$75m reverse merger of Callisto Merger Corporation, its wholly owned subsidiary, with and into Celldex Therapeutics, Inc.*

Represented Cingular Wireless LLC on its US$41bn acquisition of AT&T Wireless, creating the largest U.S. wireless carrier.*

Represented Goldman Sachs as exclusive financial advisor in numerous IPOs, spin-offs, going privates, and other M&A transactions with an average transaction range between US$1.1bn and US$5bn.*

Represented Merrill Lynch & Co. as exclusive financial advisor to Equity Office Properties Trust on its going-private acquisition by The Blackstone Group for approximately US$39bn.*

Represented Telewest Global Inc. on its US$11bn cross-border merger with NTL Incorporated, creating the largest cable company in the U.K. and Ireland.*

Represented a commercial stage, NASDAQ pharmaceutical company during its evaluation of several potential strategic transactions/alliances for the company's core assets.*

Represented IMCO Recycling Inc. on its US$2bn merger with Commonwealth Industries Inc., creating Aleris International, Inc.*

Represented a Fortune 500 global distillery company during its evaluation of several potential strategic targets in the U.S.*

Represented Vornado Realty Trust on the sale of 20.7% of its stake in AmeriCold Realty Trust, a joint venture with an enterprise value of US$1.5bn, for approximately US$145m.*

Represented Digitas Inc. on its acquisition by Publicis Groupe, via a cross-border cash tender offer for approximately US$1.3bn.*

Represented Royal Philips Electronics on NAVTEQ's US$1.0bn initial public offering.*

Represented Stride Rite Corp. on its acquisition by Collective Brands Inc. (f.k.a. Payless ShoeSource, Inc.) for approximately US$900m.*

Represented Computer Associates International, Inc. on its acquisition of Niku Corporation, in an all-cash merger valued at approximately US$350m.*

Represented Computer Associates International, Inc. on its acquisition of Concord Communications, Inc., in an all-cash merger valued at approximately US$350m.*

Represented Optium Corporation on its US$211m stock-for-stock "merger of equals" with Finisar Corp.*

Represented Clayton Holdings, Inc., on its approximately US$158m going private transaction with Greenfield Partners, LLC.*

Represented Hershey Food Corporation on its US$130m acquisition of Mauna Loa Macadamia Nut Corporation from affiliates of The Shansby Group.*

A large-cap global travel technology company, as in-house counsel, during its spin-off and IPO from Expedia, Inc., and subsequent M&A and securities transactions.*

Represented Prudential Financial, Inc. on its US$1.26bn cross border acquisition of Skandia U.S. Inc.*

*Matter handled prior to joining Hogan Lovells.

Loading data